Recipient Minus Donor Body Mass Index Difference and One-Year Graft Function After Living-Donor Kidney Transplantation
- 1Department of Nephrology, Gazi Yaşargil Training and Research Hospital, Diyarbakır 21070, Türkiye
Abstract
Background: Recipient minus donor body mass index (BMI) difference is an anthropometric exposure whose anatomical validity is unproven. We evaluated its association with 1-year graft function after living-donor kidney transplantation. Methods: This retrospective cohort included all 249 adult living-donor kidney transplant recipients at one center during 2013–2024. Adjusted linear regression assessed 1-year estimated glomerular filtration rate (eGFR) among recipients alive with functioning grafts. The sensitivity, 6-month, longitudinal, ranked-composite, and clinical-event analyses were exploratory, without adjustment for multiple comparisons. Results: All 14 recipients without 1-year eGFR had experienced graft loss or death, leaving 235 for the primary analysis. The adjusted estimate was −0.55 mL/min/1.73 m2 per kg/m2 BMI difference (95% confidence interval [CI] −1.06 to −0.05; p = 0.033), equivalent to −2.77 (95% CI −5.31 to −0.23) per 5 kg/m2. Alternative BMI parameterizations showed similar fit. Exploratory eGFR estimates varied by visit and model specification. The unadjusted graft-loss/death hazard ratio was 0.88 per 5 kg/m2 (95% CI 0.55–1.42; 14 events). The full-cohort ranked-composite interval included zero. Conclusions: The adjusted eGFR association describes survivors with functioning grafts; complementary exploratory analyses do not change this conditional interpretation. Residual confounding remains possible. BMI difference does not quantify anatomical size mismatch, and these findings do not establish causality or donor-selection thresholds.
Related
- Urinary Single-Cell Transcriptomics in Kidney Transplantation: Elucidation of Donor–Recipient Cellular Dynamics and Fibrogenic Stress
- Donor–recipient Hepatitis B serological patterns and post-transplant HBV events in pediatric living donor liver transplantation: a single-center retrospective cohort with a nested case series
- Myelodysplastic syndrome after COVID-19 infection in a living-donor kidney transplant recipient: a case report and literature review
- Racial and Ethnic Disparities in Living Donor Kidney Transplantation in California: 2010-2024
- Severe Hyponatremia as an Early Manifestation of Peritransplant Abscess After Living Donor Kidney Transplantation: A Case Report.
BibTeX
@article{eynel2026recipient,
title = {{Recipient Minus Donor Body Mass Index Difference and One-Year Graft Function After Living-Donor Kidney Transplantation}},
author = {Eren Eynel and Idris Oruc and Hasan Ince and Enver Yuksel and Ramazan Danis},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218298},
url = {https://www.mdpi.com/2077-0383/15/21/8298},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Recipient Minus Donor Body Mass Index Difference and One-Year Graft Function After Living-Donor Kidney Transplantation
AU - Eren Eynel
AU - Idris Oruc
AU - Hasan Ince
AU - Enver Yuksel
AU - Ramazan Danis
PY - 2026
DA - 2026/10/25
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218298
UR - https://www.mdpi.com/2077-0383/15/21/8298
AB - Background: Recipient minus donor body mass index (BMI) difference is an anthropometric exposure whose anatomical validity is unproven. We evaluated its association with 1-year graft function after living-donor kidney transplantation. Methods: This retrospective cohort included all 249 adult living-donor kidney transplant recipients at one center during 2013–2024. Adjusted linear regression assessed 1-year estimated glomerular filtration rate (eGFR) among recipients alive with functioning grafts. The sensitivity, 6-month, longitudinal, ranked-composite, and clinical-event analyses were exploratory, without adjustment for multiple comparisons. Results: All 14 recipients without 1-year eGFR had experienced graft loss or death, leaving 235 for the primary analysis. The adjusted estimate was −0.55 mL/min/1.73 m2 per kg/m2 BMI difference (95% confidence interval [CI] −1.06 to −0.05; p = 0.033), equivalent to −2.77 (95% CI −5.31 to −0.23) per 5 kg/m2. Alternative BMI parameterizations showed similar fit. Exploratory eGFR estimates varied by visit and model specification. The unadjusted graft-loss/death hazard ratio was 0.88 per 5 kg/m2 (95% CI 0.55–1.42; 14 events). The full-cohort ranked-composite interval included zero. Conclusions: The adjusted eGFR association describes survivors with functioning grafts; complementary exploratory analyses do not change this conditional interpretation. Residual confounding remains possible. BMI difference does not quantify anatomical size mismatch, and these findings do not establish causality or donor-selection thresholds.
SN - 2077-0383
ER -